Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

First AI-enabled POCUS app for detecting pleural effusion and atelectasis earns FDA clearance
The apps are embedded into the Exo Iris transducer, which can be plugged directly into a smartphone, utilized anywhere and without the internet.
Symptom-detected breast cancers more likely to require mastectomy, chemotherapy
New research adds to the “strong evidence” supporting screening guidelines and highlights the importance of women adhering to clinical recommendations.
Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs
POCUS could represent a quick, easy and affordable way to detect signs of insulin resistance before it progresses into diabetes, researchers suggest.
Contrast-enhanced mammography significantly improves early cancer detection
New trial results suggest CEM could enhance breast cancer detection beyond DBT exams when patients are faced with barriers to obtaining an MRI.
Bayer seeks FDA approval for gadoquatrane, its latest low-dose GBCA
The investigational agent uses 60% less gadolinium without sacrificing image quality, according to recent clinical trial findings.

ACR updates contrast guidelines, permitting non-physician providers to supervise administration

The Aug. 29 statement indicates that non-radiologist physicians, advanced practice providers and registered nurses can oversee intravenous CT and MRI contrast administration at accredited imaging centers.

Two of the top stories this month included the death of MRI pioneer Raymond Vahan Damadian. Experts at MIT also developed ultrasound stickers that can be worn in the same manner as a Band-Aid while also producing diagnostic quality images in real-time. #MRI

Top Health Imaging stories in August 2022

Here are the most popular stories on Health Imaging in August, based on our website analytics.

An overview of artificial intelligence (AI) in radiology with Keith Dreyer with the ACR. Images shows a COVID-19 lung CT scan reconstruction from Siemens Healthineers. #AI #radAI #ACR

AI speeds, improves chest X-ray interpretations

Six radiologists interpreting around 500 chest radiographs with an assist from AI bested unaided radiologists in measures of efficiency and/or accuracy in a new comparative performance study.

MRI exams reveal the impact of steroid use on the brain

Experts involved in the study suggest that their findings could help explain the neuropsychiatric effects seen in many patients who are prescribed steroids long-term.

Automated CT body composition analysis predicts risk of stroke and heart attack

Researchers observed visceral fat area (VFA) measurements derived from abdominal CT scans to be associated with increased cardiovascular risk.

Experts describe how long-term lung abnormalities of COVID patients present on imaging

Up to one-third of patients hospitalized with COVID-19 pneumonia have abnormalities on chest CT 12 months after infection.

Breast cancer screening a bellwether service in radiology’s drive to bridge the ‘digital divide’

Mammography practices need to continue supporting pre-Digital Age channels for patients to schedule appointments, participate in community health programs and receive annual screening exams in mobile settings close to where they live.

Synthetic MRI measures predict breast cancer treatment responses, according to new research

Researchers suggested that the quantitative measures derived from synthetic MRI exams could be used to help guide treatment decisions for breast cancer patients.

Medical Imaging

First AI-enabled POCUS app for detecting pleural effusion and atelectasis earns FDA clearance

Symptom-detected breast cancers more likely to require mastectomy, chemotherapy

Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs

Contrast-enhanced mammography significantly improves early cancer detection

Bayer seeks FDA approval for gadoquatrane, its latest low-dose GBCA